• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE® VIABAHN® ENDOPROSTHESIS; NIP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE® VIABAHN® ENDOPROSTHESIS; NIP Back to Search Results
Catalog Number JHH101002J
Device Problem Patient-Device Incompatibility (2682)
Patient Problems Infarction, Cerebral (1771); Thromboembolism (2654)
Event Date 02/13/2018
Event Type  Injury  
Manufacturer Narrative
The review of the manufacturing paperwork verified that this lot met all pre-release specifications.According to the gore® viabahn® endoprosthesis instructions for use (ifu), device- and/or procedure-related complications and adverse events include, but are not limited to distal embolism.Device udi lot/serial: 15852332, udi: (b)(4).
 
Event Description
On (b)(6) 2018, the patient underwent endovascular reintervention to treat a retrograde thoracic aortic dissection which had been formed around the proximal end of an existing endoprosthesis.A conformable gore® tag® thoracic endoprosthesis was implanted proximal to the existing endoprosthesis.A gore® viabahn® endoprosthesis (jhh101002j/15852332) was also deployed as a chimney device in the left subclavian artery.Intra-procedure imaging revealed a suspected cerebral infarct with the patient¿s consciousness level being deteriorated.It was reported by the physician that thrombus in the aortic arch spread, which could have caused or contributed to the suspected cerebral infarct.It was determined that the endovascular reintervention would be concluded first, followed by an intervention being performed to treat the suspected cerebral infarct.Another conformable gore® tag® thoracic endoprosthesis was implanted.The patient tolerated the procedure and a neurosurgeon underwent an intervention for the suspected cerebral infarct.A brain ct was performed but any apparent vessel obstruction was not confirmed.The neurosurgeon elected to monitor the suspected cerebral infarct.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® VIABAHN® ENDOPROSTHESIS
Type of Device
NIP
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
yutaka uchiya
1500 n. 4th street
flagstaff, AZ 
9285263030
MDR Report Key7295447
MDR Text Key100891053
Report Number2017233-2018-00127
Device Sequence Number1
Product Code PFV
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P130006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial
Report Date 02/13/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/25/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/21/2019
Device Catalogue NumberJHH101002J
Device Lot Number15852332
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/21/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age80 YR
-
-